Attomarker
Jonathan Snicker's work experience is as follows:
- Chief Strategy Officer (CSO) at Attomarker since December 2021. Attomarker is a company that specializes in nanophotonic tests for biomarkers, particularly in the field of COVID-19. The technology has been validated through the pandemic and has potential applications in various health areas.
- Member Board Of Trustees at YMCA Exeter since September 2017. This role involves being part of the governing body of the organization.
- Head of Philanthropy at the University of Exeter from January 2018 to October 2021. This position involved leading the university's philanthropic efforts.
- Senior Consultant and Associate at Graham-Pelton Consulting, Inc. from December 2014 to August 2017. This role required providing consulting services in the field of philanthropy.
- Investor Relations and Director at Husky Finance from December 2014 to December 2016. This involved managing relationships with investors and serving as a director for the company.
- Interim CEO and Strategic Counsel at DCU Educational Trust from October 2015 to August 2016. This position required temporarily leading the organization and providing strategic advice.
- Fellow for Development at St John's College, University of Oxford from April 2007 to August 2014. This role involved fundraising and development activities for the college.
- Director of Development at Exeter College from March 2000 to July 2006. This position involved managing the college's development initiatives.
- Lecturer in Politics at Oxford from March 1998 to March 2000. This role involved teaching politics at the university.
Jonathan Snicker completed their education in a chronological order. Jonathan first attended Ysgol Gyfun y Graig, although the specific years and degree obtained are not provided. Subsequently, from 1990 to 1992, they pursued a Master's degree in Political Science and International Relations at The University of Georgia. Finally, from 1986 to 1996, Jonathan obtained a D.Phil. degree in Political Science and Government from the University of Oxford.
This person is not in any teams
This person is not in any offices
Attomarker
Attomarker is a spin-out company from the University of Exeter, a member of the UK’s Russell Group of research-intensive universities. The company’s founder, Professor Andrew Shaw, leads a team of scientists and engineers across the UK & Germany. Backed by six patents and referenced in 17 academic journals, Attomarker works. Realising thevision that has inspired many, but has, until now, proved so hard to turn into reality. Patented Attomarker technology collects the blood on a disposable credit-card sized chip which slots into a mobile pocket-sized devise, docked to an iPhone. The camera visualises the blood tests which are then interpreted by the iPhone. Test results can be shared, linked to electronic patient record systems and an AI Symptom checker for diagnosis. A tele-consultation will be available via the phone. Planned launch tests include Food Allergy (covering the eight food allergens that account for 95% of all), Pregnancy (replacing unreliable and undignified urine tests) and C-reactive protein, the 21st C thermometer, (identifying infection faster than changes in temperature). Research projects that will follow include fifth generation HIV testing, infectious diseases such as Zika and Ebola, Alzheimer’s, immunotherapy cohort surveillance, sepsis and a vitamin panel test. Attomarker intends to develop three sales channels - private doctors, pharmacies and direct to consumer.